The REACT programme is made up of four different research programmes related to COVID-19 in England:

REACT studies

Graphic of a nose and throat swab

REACT-1

Each month during the pandemic over 150,000 randomly selected people across England were sent a nose/throat swab test to take at home. This study helped us understand how many people were infected with the coronavirus, including those are weren't showing symptoms.

Find out more

Graphic of an antibody test

REACT-2

Our REACT-2 study looked at how many people already had COVID-19 and developed antibodies against the virus. A number of different studies assessed the accuracy and usability of different antibody tests. These were then used to enhance our understanding of the spread of COVID-19 across England.

Find out more

REACT Long COVID

The REACT Long COVID (REACT-LC) study seeks to understand how biological, environmental and social factors determine why some people who are infected with COVID-19 continue to have symptoms for several weeks or months – a condition called Long Covid - while others don’t. The study draws on the 2.4 million REACT participants.

Find out more

REACT Children and Young People

The REACT Children and Young People study involves follow-up of over 10,000 children aged 5-17 years to investigate socio-demographic factors affecting why some children get Long COVID and others don’t, and the impact of Long COVID.

Find out more

Contact us

For survey queries only   

Email admin@react.imperial.ac.uk

Please note that when support emails are answered, they will come from the email address support.react@cognitron.co.uk  

Phone: 0207 365 8181 

Support by phone and email will be available from 9am to 5pm, Monday to Friday

For general REACT enquiries 

Email: react.study@imperial.ac.uk

Media

For media or communications enquiries only please contact: Jack Stewart

  • Join
  • Free

REACT: COVID-19 Community Network

For the public, patients and REACT participants who want to stay informed and involved in our ongoing COVID-19 and Long COVID research.